Abstract

MILLAN-GUERRERO, Rebeca Olivia  and  ISAIS-MILLAN, Sara. Cannabis and the exocannabinoid and endocannabinoid systems. Their use and controversies. Gac. Méd. Méx [online]. 2019, vol.155, n.5, pp.471-474.  Epub July 01, 2021. ISSN 2696-1288.  https://doi.org/10.24875/gmm.m20000334.

Cannabis (marijuana) is one of the most consumed psychoactive substances in the world. The term marijuana is of Mexican origin. The primary cannabinoids that have been studied to date include cannabidiol and delta-9-tetrahydrocannabinol, which is responsible for most cannabis physical and psychotropic effects. Recently, the endocannabinoid system was discovered, which is made up of receptors, ligands and enzymes that are widely expressed in the brain and its periphery, where they act to maintain balance in several homeostatic processes. Exogenous cannabinoids or naturally-occurring phytocannabinoids interact with the endocannabinoid system. Marijuana must be processed in a laboratory to extract tetrahydrocannabinol and leave cannabidiol, which is the product that can be marketed. Some studies suggest cannabidiol has great potential for therapeutic use as an agent with antiepileptic, analgesic, anxiolytic, antipsychotic, anti-inflammatory and neuroprotective properties; however, the findings on cannabinoids efficacy and cannabis-based medications tolerability-safety for some conditions are inconsistent. More scientific evidence is required in order to generate recommendations on the use of medicinal cannabis.

Keywords : Psychoactive substances; Cannabinoids; Endocannabinoid system.

        · text in English     · English ( pdf )